Останнi рекомендацiї щодо застосування розчинiв гiдроксиетилкрохмалю. Огляд сучасної лiтератури

Ф. С. Глумчер, А. Н. Семянкив, Е. В. Стрепетова

Анотація


Iнфузiйна терапiя є важливим компонентом лiкування практично всiх видiв шоку i взагалi iнтенсивної терапiї. У статтi обговорюються основнi проблеми вибору розчинiв для iнфузiйної терапiї. Акцент робиться на застосуваннi розчинiв гiдроксиетилкрохмалiв (ГЕК). Автори наводять короткi iсторичнi данi щодо розчинiв для iнфузiйної терапiї. Розглядають вплив молекулярної ваги розчинiв ГЕК на несприятливi ефекти iнфузiйної терапiї, проводять порiвняння ГЕК з кристалоїдними розчинами, наводять рiзнi данi про безпеку та ефективнiсть ГЕК в порiвняннi з альбумiном та iншими напiвсинтетичними колоїдами. Також наводяться останнi рекомендацiї щодо застосування цих розчинiв у складi iнфузiйної терапiї.

Ключові слова


iнфузiйна терапiя; розчини гiдроксиетилкрохмалiв; показання; протипоказання; безпека

Повний текст:

PDF (Русский)

Посилання


Westphal GA. How to guide volume expansion in severe sepsis and septic shock patients? Possibilities in the real world. Shock, 2013;39 Suppl 1:38-41.

Myburgh JA., Mythen MG. Resuscitation Fluids. N Engl J Med, 2013;369:1243-51.

Zampieri FG, Park M, Azevedo LC. Colloids in sepsis: evenly distributed molecules surrounded by uneven questions. Shock, 2013;39 Suppl 1:42-9.

Finfer S, Liu B, Taylor C, et al. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care, 2010;14: R185.

Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg, 2013;116(1):35-48.

Gattas DJ, Dan A, Myburgh J, et al; CHEST Management Committee. Collaborators (18) Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med, 2013;39(4):558-68.

Gillies MA, Habicher M, Jhanji S, et al. Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: systematic review and meta-analysis. Br J Anaesth, 2014;112(1):25-34.

Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med, 2008;358:125-39.

Patel A, Waheed U, Brett SJ. Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis . Intensive Care Med, 2013;39(5):811-22.

Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA, 2013 20;309(7):678-88.

Bayer O, Schwarzkopf D, Doenst T, et al. Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery--a prospective sequential analysis.Crit Care Med, 2013;41(11):2532-42.

Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med, 2008;358:125-39.

Kozek-Langenecker SA, Jungheinrich C, et al. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials.Anesth Analg, 2008;107(2):382-90.

Cabrales P, Tsai AG, Intaglietta M. Resuscitation from hemorrhagic shock with hydroxyethyl starch and coagulation changes. Shock, 2007;28(4):461-7.

Simon TP, Schuerholz T, Haugvik SP, et al. High molecular weight hydroxyethyl starch solutions are not more effective than a low wmolecular weight hydroxyethyl starch solution in a porcine model of septic shock. Minerva Anestesiol, 2013;79(1):44-52.

Matharu NM, Butler LM, Rainger GE, et al. Mechanisms of the anti-inflammatory effects of hydroxyethyl starch demonstrated in a flow-based model of neutrophil recruitment by endothelial cells.Crit Care Med, 2008;36(5):1536-42.

Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg, 2013;116(1):35-48.

Zaar M, Lauritzen B, Secher NH. Initial administration of hydroxyethyl starch vs lactated Ringer after liver trauma in the pig. Br J Anaesth, 2009;102(2):221-6.

Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med, 2012;367:1901-11.

Inan N, Iltar S, Surer H, Effect of hydroxyethyl starch 130/0.4 on ischaemia/reperfusion in rabbit skeletal muscle. Eur J Anaesthesiol, 2009;26(2):160-50.

Kimberger O, Arnberger M, Brandt S, et al. Goal-directed colloid administration improves the microcirculation of healthy and perianastomotic colon. Anesthesiology, 2009;110(3):496-504.

Xiong L, Lei C, Wang Q, Li W. Acute normovolaemic haemodilution with a novel hydroxyethyl starch (130/0.4) reduces focal cerebral ischaemic injury in rats. Eur J Anaesthesiol, 2008;25(7):581-8.

Kheirabadi BS, Crissey JM, Deguzman R, J // Trauma. 2008;64(5):1218-28.

Bayer O, Reinhart K, Sakr Y, et al. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Crit Care Med, 2011;39:1335-42.4.

Osthaus WA, Witt L, Johanning K, Boethig D, Equal effects of gelatin and hydroxyethyl starch (6% HES 130/0.42) on modified thrombelastography in children. Acta Anaesthesiol Scand, 2009;53(3):305-10.

Varga R, T?r?k L, Szab? A, et al. Effects of colloid solutions on ischemia-reperfusion-induced periosteal microcirculatory and inflammatory reactions: comparison of dextran, gelatin, and hydroxyethyl starch.Crit Care Med, 2008;36(10):2828-37.

Godet G, Lehot JJ, Janvier G, et al. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction under going abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.Eur J Anaesthesiol, 2008;25(12):986-94.

Mittermayr M, Streif W, Haas T, et al. Effects of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo. Br J Anaesth, 2008;100(3):307-14.

PRAC confirms that hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients. 11 October 2013 EMA/606303/2013.

Vincent Jean-Louis and De Backer Daniel. Circulatory Shock. N Engl J Med, 2013;369:1726-34.


Пристатейна бібліографія ГОСТ






DOI: http://dx.doi.org/10.25284/2519-2078.1(66).2014.85614

Посилання

  • Поки немає зовнішніх посилань.


Creative Commons License
Ця робота ліцензована Creative Commons Attribution-NonCommercial 4.0 International License.

© Асоціація анестезіологів України, 1997-2017. ISSN 2520-226X (Online), ISSN 2519-2078 (Print).

Flag Counter